PI
VRTX icon

PFG Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

PFG Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$953K Sell
2,134
-9
-0.4% -$4.2K 0.04% 371
2025
Q4 		$972K Buy
2,143
+25
+1% +$10.8K 0.05% 355
2025
Q3 		$829K Buy
2,118
+246
+13% +$103K 0.04% 385
2025
Q2 		$833K Buy
1,872
+60
+3% +$27.6K 0.05% 351
2025
Q1 		$878K Sell
1,812
-5
-0.3% -$2.33K 0.06% 330
2024
Q4 		$732K Buy
1,817
+44
+2% +$20.4K 0.05% 367
2024
Q3 		$825K Buy
1,773
+31
+2% +$14.9K 0.05% 342
2024
Q2 		$817K Sell
1,742
-267
-13% -$116K 0.06% 311
2024
Q1 		$840K Buy
2,009
+209
+12% +$88.4K 0.05% 370
2023
Q4 		$732K Buy
1,800
+1,004
+126% +$371K 0.14% 170
2023
Q3 		$277K Sell
796
-7
-0.9% -$2.45K 0.05% 368
2023
Q2 		$283K Buy
+803
New +$271K 0.05% 378

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

PFG Investments's VRTX Position: Q1 2026 in Review

PFG Investments reduced its Vertex Pharmaceuticals (VRTX) stake by 0.42% in Q1 2026, selling an estimated $4.2K and leaving 2,134 shares worth $953K. The position accounts for 0.04% of the portfolio, ranked #371.

PFG Investments first reported a position in VRTX in Q2 2023 and has held it in 12 quarters since. The position peaked at $972K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • PFG Investments held 2,134 shares of Vertex Pharmaceuticals worth $953K as of Q1 2026.
  • PFG Investments sold 9 Vertex Pharmaceuticals shares in Q1 2026, an estimated $4.2K.
  • Vertex Pharmaceuticals made up 0.04% of PFG Investments's portfolio in Q1 2026, its #371 holding.
  • PFG Investments first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
  • PFG Investments's Vertex Pharmaceuticals position peaked at $972K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.